134380 — Miwon Chemicals Co Balance Sheet
0.000.00%
- KR₩177bn
- KR₩105bn
- KR₩256bn
- 87
- 91
- 42
- 89
Annual balance sheet for Miwon Chemicals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,653 | 6,595 | 12,962 | 26,540 | 48,546 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19,337 | 29,910 | 29,978 | 36,874 | 36,566 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 39,991 | 54,075 | 62,838 | 80,680 | 105,312 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 81,692 | 75,696 | 81,215 | 79,802 | 77,818 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 125,336 | 133,843 | 147,864 | 164,771 | 187,153 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,374 | 5,401 | 6,792 | 12,114 | 15,056 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,431 | 13,888 | 15,155 | 20,282 | 24,782 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 112,905 | 119,955 | 132,709 | 144,489 | 162,371 |
| Total Liabilities & Shareholders' Equity | 125,336 | 133,843 | 147,864 | 164,771 | 187,153 |
| Total Common Shares Outstanding |